Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
J Clin Oncol
; 36(15): 1469-1477, 2018 05 20.
Article
in En
| MEDLINE
| ID: mdl-29620995
Full text:
1
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Colonic Neoplasms
/
Oxaliplatin
Type of study:
Clinical_trials
Country/Region as subject:
Europa
Language:
En
Journal:
J Clin Oncol
Year:
2018
Type:
Article